Malin Corporation | MLC - SCHULD





SCHULD Veränderung Datum
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
ALKERMES USD 71.6M 1.08M 2025-09
Avita Medical AUD 46.05M 1.46M 2025-12
Dianthus Therapeutics USD 1.28M 45K 2025-09
Eurofins Scientific SE EUR 4.11B 503.4M 2025-06
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
IQVIA Holdings USD 15.72B 767M 2025-12
Lonza CHF 4.71B 915M 2024-12
Malin Corporation EUR 100K 0 2023-12
Moderna USD 734M 7M 2025-09
Organon & Co USD 8.83B 68M 2025-09
Ovoca Bio EUR 0 0 2021-06
Revvity USD 3.37B 5.86M 2025-09
Tectonic Therapeutic USD 876K 115K 2024-12
Viatris USD 14.41B 25.6M 2025-12
Xeris Pharmaceuticals USD 257.65M 431K 2025-09